Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Change in Inventory (2019 - 2025)

Marimed (MRMD) has disclosed Change in Inventory for 7 consecutive years, with -$2.9 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory fell 96.84% to -$2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6000.0 through Dec 2025, down 99.93% year-over-year, with the annual reading at $6000.0 for FY2025, 99.93% down from the prior year.
  • Change in Inventory for Q4 2025 was -$2.9 million at Marimed, down from $1.2 million in the prior quarter.
  • The five-year high for Change in Inventory was $3.8 million in Q3 2024, with the low at -$2.9 million in Q4 2025.
  • Average Change in Inventory over 5 years is $1.1 million, with a median of $1.2 million recorded in 2025.
  • The sharpest move saw Change in Inventory tumbled 4435.22% in 2021, then surged 760.24% in 2024.
  • Over 5 years, Change in Inventory stood at -$1.2 million in 2021, then surged by 195.27% to $1.2 million in 2022, then fell by 5.74% to $1.1 million in 2023, then crashed by 235.06% to -$1.5 million in 2024, then plummeted by 96.84% to -$2.9 million in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at -$2.9 million, $1.2 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.